Literature DB >> 33543786

Bladder and bowel incontinence in COVID-19.

Mohammad Pourfridoni1, Mojde Pajokh2, Fatemeh Seyedi2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33543786      PMCID: PMC8014136          DOI: 10.1002/jmv.26849

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


× No keyword cloud information.

PEER REVIEW

The peer review history for this article is available at https://publons.com/publon/10.1002/jmv.26849. To the Editor, Coronavirus 2019 (COVID‐19) or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an acute respiratory disease that has infected more than 99 million people and killed more than two million people as of January 26, 2021. COVID‐19 has various manifestations such as respiratory, cardiovascular, gastrointestinal, renal, neurological, and so forth. With the increase in research about COVID‐19, various neurological complications have been reported in these patients. Some of the neurological complications that have been reported in COVID‐19 patients include headache, anosmia, hyposmia, dysgeusia, impaired consciousness, seizures, encephalitis, demyelinating neuropathy. , SARS‐CoV‐2 can directly or indirectly damage neurons by invading the central nervous system and peripheral nervous system. The pro‐inflammatory “cytokine storm” caused by SARS‐CoV‐2 infection can cause neuroinflammation, which eventually leads to neuron  demyelination. It has already been proven that some viral infections cause various demyelinating diseases in animals and humans. Demyelinating neuropathy is one of the COVID‐19 neurological complications. Neuron demyelination can cause several disorders. Some of them include diplopia, ataxia, clonus, dysarthria, paraesthesia in hands and feet, hemiparesis, incoordination, weakness, unsteadiness, and hearing loss. , Demyelinating disorders have a wide range and are not limited to the cases mentioned. For example, acute demyelinating inflammatory polyneuropathy, the most common type of Guillain‐Barré syndrome, has been reported as a complication in patients with COVID‐19. To the best of our knowledge, inflammation, and demyelination in the pudendal nerve can lead to bladder and bowel incontinence. , Pudendal neuropathy was reported in some viral infections such as HIV and herpes zoster, and multiple sclerosis. Due to innervation of anal and urethral sphincter by the pudendal nerve, It seems COVID‐19 by inflammation and demyelination in the pudendal nerve, causes bladder and bowel incontinence. Therefore, these COVID‐19 probable neurological complications should be considered important because they can have diagnostic value. Hence, medical staff should consider the possibility of COVID‐19 in a suspected patient if they observe these symptoms, and also, people should be aware of COVID‐19 when faced with these symptoms. Awareness of the broader symptoms of the disease can lead to a faster therapeutic procedure and consequently reduce the mortality rate.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.
  9 in total

1.  Value of the pudendal nerves terminal motor latency measurements in the diagnosis of occult stress urinary incontinence.

Authors:  Lan Zhu; Ning Hai; Jing-He Lang; Shi-Yun Yu; Bin Li; Felix Wong
Journal:  Chin Med J (Engl)       Date:  2011-12       Impact factor: 2.628

2.  Atypical Cauda Equina Syndrome with Lower Limb Clonus: A Literature Review and Case Report.

Authors:  Asfand Baig Mirza; Melika Akhbari; Jose P Lavrador; Eleni C Maratos
Journal:  World Neurosurg       Date:  2019-11-09       Impact factor: 2.104

3.  Neurological manifestations of COVID-19: a systematic review.

Authors:  Gaurav Nepal; Jessica Holly Rehrig; Gentle Sunder Shrestha; Yow Ka Shing; Jayant Kumar Yadav; Rajeev Ojha; Gaurab Pokhrel; Zhi Lan Tu; Dong Ya Huang
Journal:  Crit Care       Date:  2020-07-13       Impact factor: 9.097

4.  Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.

Authors:  V Montalvan; J Lee; T Bueso; J De Toledo; K Rivas
Journal:  Clin Neurol Neurosurg       Date:  2020-05-15       Impact factor: 1.876

Review 5.  Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies.

Authors:  Giuseppe Preziosi; Ayeshah Gordon-Dixon; Anton Emmanuel
Journal:  Degener Neurol Neuromuscul Dis       Date:  2018-12-06

Review 6.  Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.

Authors:  Erika Scheidl; Daniel Diez Canseco; Aleksandar Hadji-Naumov; Benjamin Bereznai
Journal:  J Peripher Nerv Syst       Date:  2020-05-26       Impact factor: 3.494

Review 7.  Virus demyelination.

Authors:  John K Fazakerley; Robert Walker
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Long-Term Respiratory and Neurological Sequelae of COVID-19.

Authors:  Fuzhou Wang; Richard M Kream; George B Stefano
Journal:  Med Sci Monit       Date:  2020-11-01

Review 9.  Neurological associations of COVID-19.

Authors:  Mark A Ellul; Laura Benjamin; Bhagteshwar Singh; Suzannah Lant; Benedict Daniel Michael; Ava Easton; Rachel Kneen; Sylviane Defres; Jim Sejvar; Tom Solomon
Journal:  Lancet Neurol       Date:  2020-07-02       Impact factor: 44.182

  9 in total
  2 in total

1.  Urodynamically proven lower urinary tract dysfunction in children after COVID-19: A case series.

Authors:  Ismail Selvi; Muhammet İrfan Dönmez; Orhan Ziylan; Tayfun Oktar
Journal:  Low Urin Tract Symptoms       Date:  2022-03-15       Impact factor: 1.374

Review 2.  Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems.

Authors:  Nicholas L DePace; Joe Colombo
Journal:  Curr Cardiol Rep       Date:  2022-09-30       Impact factor: 3.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.